These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
371 related items for PubMed ID: 2547470
1. Change in cough reflex after treatment with enalapril and ramipril. McEwan JR, Choudry N, Street R, Fuller RW. BMJ; 1989 Jul 01; 299(6690):13-6. PubMed ID: 2547470 [Abstract] [Full Text] [Related]
3. A multi-centre comparative study between ramipril and enalapril in patients with mild to moderate essential hypertension. Zabludowski J, Rosenfeld J, Akbary MA, Rangoonwala B, Schinzel S. Curr Med Res Opin; 1988 Jul 01; 11(2):93-106. PubMed ID: 2851414 [Abstract] [Full Text] [Related]
5. A double-blind study to compare the efficacy, tolerance and safety of two doses of the angiotensin converting enzyme inhibitor ramipril with placebo. Villamil AS, Cairns V, Witte PU, Bertolasi CA. Am J Cardiol; 1987 Apr 24; 59(10):110D-114D. PubMed ID: 3034017 [Abstract] [Full Text] [Related]
6. Comparative double-blind study of ramipril and captopril in mild to moderate essential hypertension. Witte PU, Walter U. Am J Cardiol; 1987 Apr 24; 59(10):115D-120D. PubMed ID: 3034018 [Abstract] [Full Text] [Related]
12. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats. Moursi MG, Ganten D, Lang RE, Unger T. J Hypertens Suppl; 1986 Oct 24; 4(3):S495-8. PubMed ID: 3023591 [Abstract] [Full Text] [Related]
14. Efficacy, tolerance and hormonal effects of a new oral angiotensin converting enzyme inhibitor, ramipril (HOE 498), in mild to moderate primary hypertension. Karlberg BE, Lindström T, Rosenqvist U, Ohman KP. Am J Cardiol; 1987 Apr 24; 59(10):104D-109D. PubMed ID: 3034016 [Abstract] [Full Text] [Related]
15. Short- and long-term effects of ramipril in hypertension. de Leeuw PW, Birkenhäger WH. Am J Cardiol; 1987 Apr 24; 59(10):79D-82D. PubMed ID: 3034038 [Abstract] [Full Text] [Related]
16. Effect of dose adjustment on enalapril-induced cough and the response to inhaled capsaicin. Yeo WW, Higgins KS, Foster G, Jackson PR, Ramsay LE. Br J Clin Pharmacol; 1995 Mar 24; 39(3):271-6. PubMed ID: 7619668 [Abstract] [Full Text] [Related]
17. Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: comparison with enalapril (MK421) and ramipril (Hoe498). Unger T, Moursi M, Ganten D, Hermann K, Lang RE. J Cardiovasc Pharmacol; 1986 Mar 24; 8(2):276-85. PubMed ID: 2422465 [Abstract] [Full Text] [Related]
18. The effect of an angiotensin converting enzyme inhibitor, ramipril, on bronchial responses to inhaled histamine and bradykinin in asthmatic subjects. Dixon CM, Fuller RW, Barnes PJ. Br J Clin Pharmacol; 1987 Jan 24; 23(1):91-3. PubMed ID: 3028458 [Abstract] [Full Text] [Related]
19. Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo. Rake EC, Breeze E, Fletcher AE. J Hum Hypertens; 2001 Dec 24; 15(12):863-7. PubMed ID: 11773989 [Abstract] [Full Text] [Related]
20. First dose response and 24-hour antihypertensive efficacy of the new once-daily angiotensin converting enzyme inhibitor, ramipril. Heber ME, Brigden GS, Caruana MP, Lahiri A, Raftery EB. Am J Cardiol; 1988 Aug 01; 62(4):239-45. PubMed ID: 2969671 [Abstract] [Full Text] [Related] Page: [Next] [New Search]